Similar Search Results

Direct to consumer advertising in pharmaceutical markets

Brekke, Kurt R.; Kuhn, Michael - 2005

We study effects of direct-to-consumer advertising (DTCA) in the prescription drug market. There are two pharmaceutical …

Persistent link: https://www.econbiz.de/10010261296

Advertising Competition in the Free-to-Air TV Broadcasting Industry

Ivaldi, Marc; Zhang, Jiekai - 2017

This paper empirically investigates the advertising competition in the French broadcast television industry within a …, and quantities of advertising of twenty-one TV channels from March 2008 to December 2013. We specify a structural model of … French TV advertising market is of the Cournot type. Further, we provide empirical evidence that the price-cost margin is not …

Persistent link: https://www.econbiz.de/10011657182

Push-Me Pull-You: Comparative Advertising in the OTC Analgesics Industry

Anderson, Simon P.; Ciliberto, Federico; Liaukonyte, Jura; … - 2015

We derive equilibrium incentives to use comparative advertising that pushes up own brand perception and pulls down the … matrices identify diversion ratios, from which we derive comparative advertising damage measures. We find that comparative … advertising causes more damage to the targeted rival than benefit to the advertiser. We simulate banning comparative advertising …

Persistent link: https://www.econbiz.de/10011307083

Gatekeeping in health care

Brekke, Kurt R.; Nuscheler, Robert; Straume, Odd Rune - 2005

We study the competitive effects of restricting direct access to secondary care by gatekeeping, focusing on the informational role of general practitioners (GPs). In the secondary care market there are two hospitals choosing quality and specialisation. Patients, who are ex ante uninformed, can...

Persistent link: https://www.econbiz.de/10010261341

Price Regulation and Parallel Imports of Pharmaceuticals

Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - 2015

This paper studies the effects of price regulation and parallel imports in the on-patent pharmaceutical market. In a theory model where the producer price is subject to bargaining between the brand-name producer and a distributor, we show that the effects of stricter price regulation crucially...

Persistent link: https://www.econbiz.de/10011307132

Reference pricing of pharmaceuticals

Brekke, Kurt R.; Koenigbauer, Ingrid; Straume, Odd Rune - 2006

We consider a therapeutic market with potentially three pharmaceutical firms. Two of the firms offer horizontally differentiated brand-name drugs. One of the brand-name drugs is a new treatment under patent protection that will be introduced if the profits are sufficient to cover the entry...

Persistent link: https://www.econbiz.de/10010263999

Regulation and pricing of pharmaceuticals: reference pricing or price cap regulation?

Brekke, Kurt R.; Grasdal, Astrid L.; Holmås, Tor Helge - 2007

We study the relationship between regulatory regimes and pharmaceutical firms' pricing strategies using a unique policy experiment from Norway, which in 2003 introduced a reference price (RP) system called index pricing for a sub-sample of off-patent pharmaceuticals, replacing the existing price...

Persistent link: https://www.econbiz.de/10010264178

Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment

Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - 2010

We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub-sample of off-patent products. First, we construct a vertical...

Persistent link: https://www.econbiz.de/10010274913

Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform

Brekke, Kurt R.; Canta, Chiara; Straume, Odd Rune - 2022

Policy makers use reference pricing to curb pharmaceutical expenditures by reducing coverage of expensive branded drugs. In a theoretical analysis we show that the net effect of reference pricing is generally ambiguous when accounting for entry by generic producers. Reference pricing shifts...

Persistent link: https://www.econbiz.de/10013353465

Margins and market shares: Pharmacy incentives for generic substitution

Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - 2012

We study the impact of product margins on pharmacies' incentive to promote generics instead of brand-names. First, we construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to purchase a generic version instead. We show that pharmacies' substitution...

Persistent link: https://www.econbiz.de/10010291561

1
2
3
4
5
6
7
8
9
10
Next
Last